Votrient Tablet, Film Coated
Product Images NDC 0078-1077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Votrient (NDC 0078-1077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Votrient 01

Votrient 01
This is a description for a medication called Votrient, which comes in tablet form. The package contains 120 tablets, each with a strength of 200 mg. The manufacturer of the medication is Novartis, and the product is identified as NDG 0078-0670-00. The medication contains pazopanib and is produced in Singapore.*
FDA Label Image

The Following Chemical Structure For Votrient (pazopanib) Is A Tyrosine Kinase Inhibitor (tki). Pazopanib Is Presented As The Hydrochloride Salt, With The Chemical Name 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide Monohydrochloride. It Has The Molecular Formula C21h23n7o2s•hcl And A Molecular Weight Of 473.99. (Votrient 02)

The Following Chemical Structure For Votrient (pazopanib) Is A Tyrosine Kinase Inhibitor (tki). Pazopanib Is Presented As The Hydrochloride Salt, With The Chemical Name 5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide Monohydrochloride. It Has The Molecular Formula C21h23n7o2s•hcl And A Molecular Weight Of 473.99. (Votrient 02)
FDA Label Image

Figure 1. Kaplan-meier Curve For Progression-free Survival In Rcc By Independent Assessment For The Overall Population (treatment-naïve And Cytokine Pre-treated Populations) (Votrient 03)

Figure 1. Kaplan-meier Curve For Progression-free Survival In Rcc By Independent Assessment For The Overall Population (treatment-naïve And Cytokine Pre-treated Populations) (Votrient 03)
Not available.*
FDA Label Image

Figure 2. Kaplan-meier Curve For Progression-free Survival In Sts By Independent Assessment For The Overall Population (Votrient 04)

Figure 2. Kaplan-meier Curve For Progression-free Survival In Sts By Independent Assessment For The Overall Population (Votrient 04)
FDA Label Image

Principal Display Panelndc 0078-0670-66votrient(pazopanlb)tablets200 mg120 Tabletsrx Only (Votrient 05)

Principal Display Panelndc 0078-0670-66votrient(pazopanlb)tablets200 mg120 Tabletsrx Only (Votrient 05)
This is a description of the drug Votrient (pazopanib) manufactured by NovarTIs Llaas. The text includes instructions not to use it in pregnancy and mentions a tablet safety seal under the cap. The rest of the text is not-readable and contains non-English characters, so additional information cannot be provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.